Skip to main content
FinSpry Logo
FinSpry
IOVA logo
IOVA
(NASDAQ)
Iovance Biotherapeutics, Inc.
$3.43-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Iovance Biotherapeutics (IOVA) Stock Price & Financial Analysis

Iovance Biotherapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.32 - $3.51
52-Week High$5.63
52-Week Low$1.64
Open$3.34
Volume7.47M
Average Volume (3M)7.47M
Market Cap1.23B
Shares Outstanding357.35M
Price to Sales (P/S)4.68
Price to Book (P/B)1.76
EV/EBITDA-3.12
Revenue (TTM)263.50M
Net Income (TTM)-390.98M
Free Cash Flow (TTM)-336.24M
EPS (TTM)$-0.96
Profit Margin-148.38%
Operating Margin-151.12%
Return on Equity (ROE)-55.97%
Debt to Equity0.07
50-Day MA$3.38
200-Day MA$2.58
52-Week Change6.15%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Iovance Biotherapeutics

What is the current stock price for IOVA?

As of the latest trading session, IOVA stock trades at $3.43. The 52-week range is $1.64–$5.63, with a day range of $3.32–$3.50.

What is the P/E ratio for IOVA?

The P/E ratio (Price-to-Earnings) for IOVA is shown in the Key Statistics section. This valuation metric helps compare Iovance Biotherapeutics, Inc. to industry peers.

Does IOVA pay dividends?

Iovance Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IOVA?

Based on 3 analysts, the consensus for IOVA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IOVA?

Iovance Biotherapeutics's market capitalization is $1.23B, classifying it as a small-cap company. Iovance Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.